My ERA Join ERA

Home | IWG WG

IWG WG

10 / 24 results found

Extrarenal Disease in ANCA-Associated Vasculitis: Challenges and Evolving Therapeutic Strategies on behalf of the Immunonephrology Working Group (IWG) of the ERA

March 31, 2026

IWG WG

Active lupus nephritis is an orphan disease

March 11, 2026

IWG WG

Albuminuria or proteinuria in glomerular disease and CKD – which one to use?

February 17, 2026

IWG WG

The 2025 KDIGO guideline on the management of nephrotic syndrome in children: a comment of the European Renal Association Immunonephrology Working Group

December 05, 2025

IWG WG

The 2025 update of the KDIGO IgA nephropathy guidelines: An ERA Immunonephrology Working Group perspective

October 22, 2025

IWG WG

Complement activation in secondary thrombotic microangiopathies

May 15, 2025

IWG WG

Malignancies and glomerulonephritis: when to suspect and when to screen?

April 10, 2025

IWG WG

Quo Vadis Standardization of Anti-Nephrin Antibody Detection?

April 03, 2025

IWG WG

Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)

February 08, 2025

IWG WG

Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication

October 28, 2024

IWG WG